Pcn58 - Median Survival, Mean Survival or Hazard Ratio: Which Endpoint Is the Most Appropriate for Patients, Physicians and Policy Makers?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Which Access Is the Most Appropriate for Your Patient?

Journal of Nephrology & Therapeutics
2012English

On the Interpretation of the Hazard Ratio and Communication of Survival Benefit

Oncologist
Cancer ResearchMedicineOncology
2017English

The Evidence Based Efficacy of Sublingual Immunotherapy for Allergic Rhinitis, Which Is the Most Appropriate Estimate?

Journal of Allergy & Therapy
2016English

P164 Lung Cancer Survival in England: Which Patients Have Demonstrated Improved Survival?

Thorax
PulmonaryRespiratory Medicine
2012English

Table 2: Median Survival Years.

English

What Is the Most Appropriate Treatment for Patellar Tendinopathy?

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2001English

Two-Stage Optimal Designs With Survival Endpoint When the Follow-Up Time Is Restricted

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2019English

The Survival of Osteosarcoma Patients 10 Years Old or Younger Is Not Worse Than the Survival of Older Patients: A Retrospective Analysis

Cancer Research and Treatment
Cancer ResearchOncology
2007English

Visualization Techniques: Which Is the Most Appropriate in the Process of Knowledge Discovery in Data Base?

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy